Sort
130,381 grants matching “hiv”
HIV PREVENTION, CARE AND SUPPORT AND CONFIDENTIAL COUNSELING AND TESTING
$1,025,000Ruth Mufute · Africare · U62 · FY2007 · PS
Role of RhCMV in shaping the SIV proviral landscape
$1,024,940Joseph Christopher Mudd · Tulane University Of Louisiana · R01 · FY2023 · AI
Five Point Initiative: A Cluster Randomized Trial of a Bundled Implementation Strategy to Address the HIV Epidemic in Black Communities
$1,024,917Sannisha K. Dale · University Of Miami Coral Gables · R01 · FY2025 · MH
Lung cancer in East Africa and the relationship to HIV-1 infection: epidemiology, molecular characterization and imaging
$1,024,684Robert A Salata · Case Western Reserve University · U54 · FY2020 · CA
GH11-1152, S. Africa: PLANNING, IMPLEMENTATON, EVALUATION OF COMPREHENSIVE HIV PREVENTION (PEPFAR)
$1,024,261Harry Peter Hausler · Tb Hiv Care · U2G · FY2015 · GH
Virological Measurements of Cryptic Replication
$1,024,059Mario Stevenson · University Of Minnesota · P01 · FY2009 · AI
Integrated Networks of Scholars in Global Health Research Training (INSIGHT)
$1,023,897Manhattan E Charurat · University Of Maryland Baltimore · D43 · FY2023 · TW
Technology-based Treatments for Substance Use Disorders
$1,023,685Lisa A Marsch · Dartmouth College · P30 · FY2012 · DA
HIV AND THE SEXUAL NETWORKS OF IDUS AND DRUG-USING MSM
$1,023,683Lawrence J Ouellet · University Of Illinois At Chicago · U01 · FY2006 · DA
Decoding epigenetic scars of smoldering neuroinflammation and CNS complications in people with HIV
$1,023,588Michael Jay Corley · Weill Medical Coll Of Cornell Univ · R01 · FY2023 · MH
Immune checkpoint inhibitors and accelerated coronary atherosclerosis
$1,023,526Tomas G Neilan · Massachusetts General Hospital · R01 · FY2025 · HL
Influence of SIV replication on TB progression and immunity
$1,023,452Zandrea Ambrose · University Of Pittsburgh At Pittsburgh · R01 · FY2020 · AI
Philadelphia Pediatric AIDS Clinical Trials Unit
$1,023,391Childrens Hospital Of Philadelphia · U01 · FY2004 · AI
Studies of Chemokine-Receptor Interactions with Chemokines and alarmins
$1,023,149Joost J Oppenheim · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
Structural Biology Core
$1,022,795Dmitry Lyumkis · Seattle Children'S Hospital · U54 · FY2023 · AI
FAS Prevention: A Trial of the IOM Model
$1,022,507Philip Alan May · University Of New Mexico · R01 · FY2007 · AA
Clinical Trials Units for NIAID Networks (UM1)
$1,022,484Ian Matthias Sanne · Wits Health Consortium (Pty), Ltd · UM1 · FY2015 · AI
NMR Core
$1,022,410Angela M. Gronenborn · University Of Pittsburgh At Pittsburgh · U54 · FY2024 · AI
BEHAVIORAL, BASIC, AND CLINICAL STUDIES OF PEP
$1,022,377University Of California San Francisco · R01 · FY2000 · MH
Northeast Node of the National Drug Abuse Clinical Trials Network
$1,022,375Lisa A Marsch · Dartmouth College · UG1 · FY2020 · DA
ULTRAFAST OPTICAL PROCESSES LABORATORY
$1,022,346Feng Gai · University Of Pennsylvania · P41 · FY2016 · GM
Role of B Lymphocytes In HIV Infection And Pathogenesis
$1,022,245Susan Moir · National Institute Of Allergy And Infectious Diseases · ZIA · FY2015 · AI
AmbassADDOrs for Health: Supporting young women's health through girl-friendly drug vendors
$1,022,224Jenny Xin Liu · University Of California, San Francisco · R01 · FY2022 · MH
Brooklyn Health Disparities Center
$1,022,071Moro O. Salifu · Suny Downstate Medical Center · P20 · FY2013 · MD
Antigen recognition and activation of HIV-specific B cell antigen receptors
$1,022,050S Munir Alam · Duke University · R01 · FY2025 · AI